Cite
Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.
MLA
Ravelli, Andrea, et al. “Breast Cancer Circulating Biomarkers: Advantages, Drawbacks, and New Insights.” Tumor Biology (Springer Science & Business Media B.V.), vol. 36, no. 9, Aug. 2015, pp. 6653–65. EBSCOhost, https://doi.org/10.1007/s13277-015-3944-7.
APA
Ravelli, A., Reuben, J., Lanza, F., Anfossi, S., Cappelletti, M., Zanotti, L., Gobbi, A., Senti, C., Brambilla, P., Milani, M., Spada, D., Pedrazzoli, P., Martino, M., Bottini, A., & Generali, D. (2015). Breast cancer circulating biomarkers: advantages, drawbacks, and new insights. Tumor Biology (Springer Science & Business Media B.V.), 36(9), 6653–6665. https://doi.org/10.1007/s13277-015-3944-7
Chicago
Ravelli, Andrea, James Reuben, Francesco Lanza, Simone Anfossi, Maria Cappelletti, Laura Zanotti, Angela Gobbi, et al. 2015. “Breast Cancer Circulating Biomarkers: Advantages, Drawbacks, and New Insights.” Tumor Biology (Springer Science & Business Media B.V.) 36 (9): 6653–65. doi:10.1007/s13277-015-3944-7.